Andrew Cittadine
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Cittadine
Andrew Cittadine is recorded as COO at Monopar Therapeutics (MNPR). The proxy statement of Monopar Therapeutics reports total compensation of $4,706,431 for Andrew Cittadine in fiscal 2025, including a base salary of $440,000. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monopar Therapeutics
Other people whose current roles at this company are on record from its filings.
- Chandler D. Robinson CEO, Board Member
- Karthik Radhakrishnan CFO, Chief Accounting Officer
- Quan A. Vu CFO
- Quan Vu CFO, Chief Accounting Officer
- Andrew J. Cittadine COO
- Andrew P. Mazar, Ph.D. Board Member
- Arthur J. Klausner, MBA Board Member
- Chandler D. Robinson, MD MBA MSc Board Member
- Christopher M. Starr Board Member
- Christopher M. Starr, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $440,000 | $4,706,431 |
| 2024 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $384,800 | $554,796 |
| 2023 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $360,000 | $911,161 |
| 2022 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $325,000 | $752,326 |
Recent activity
No call appearances or filed executive changes recorded yet.